Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China
· Delayed Price · Currency is CNY 14.26
+0.12 (0.85%)
At close: Mar 10, 2026
SHE:002907 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,955 | 5,429 | 6,452 | 8,502 | 7,250 | 5,391 | Upgrade
|
| Market Cap Growth | 10.71% | -15.86% | -24.12% | 17.27% | 34.50% | -19.42% | Upgrade
|
| Enterprise Value | 5,422 | 4,957 | 5,999 | 8,261 | 6,982 | 5,125 | Upgrade
|
| Last Close Price | 14.26 | 12.94 | 15.28 | 20.04 | 17.70 | 13.13 | Upgrade
|
| PE Ratio | 79.84 | 70.75 | 197.31 | 86.41 | 79.00 | 45.23 | Upgrade
|
| PS Ratio | 7.57 | 7.01 | 9.33 | 10.83 | 8.57 | 6.11 | Upgrade
|
| PB Ratio | 3.48 | 3.27 | 3.99 | 5.28 | 5.73 | 4.56 | Upgrade
|
| P/TBV Ratio | 4.04 | 3.54 | 4.27 | 5.54 | 6.10 | 4.78 | Upgrade
|
| P/FCF Ratio | 88.82 | 37.28 | 50.99 | - | 276.62 | 80.52 | Upgrade
|
| P/OCF Ratio | 74.74 | 33.56 | 29.42 | 651.77 | 87.51 | 47.44 | Upgrade
|
| EV/Sales Ratio | 6.89 | 6.40 | 8.67 | 10.52 | 8.25 | 5.81 | Upgrade
|
| EV/EBITDA Ratio | 42.40 | 33.64 | 53.90 | 47.99 | 42.39 | 32.85 | Upgrade
|
| EV/EBIT Ratio | 134.12 | 79.49 | 204.04 | 84.65 | 73.53 | 46.97 | Upgrade
|
| EV/FCF Ratio | 80.86 | 34.04 | 47.41 | - | 266.38 | 76.56 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0 | 0 | 0 | 0.20 | 0.21 | Upgrade
|
| Debt / EBITDA Ratio | 0.30 | 0.00 | 0.00 | 0.00 | 1.52 | 1.59 | Upgrade
|
| Debt / FCF Ratio | 0.58 | 0.00 | 0.00 | - | 9.58 | 3.70 | Upgrade
|
| Net Debt / Equity Ratio | -0.32 | -0.37 | -0.30 | -0.31 | -0.20 | -0.24 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.34 | -4.12 | -4.38 | -2.92 | -1.57 | -1.82 | Upgrade
|
| Net Debt / FCF Ratio | -8.27 | -4.17 | -3.85 | 10.58 | -9.90 | -4.24 | Upgrade
|
| Asset Turnover | 0.40 | 0.41 | 0.37 | 0.43 | 0.48 | 0.53 | Upgrade
|
| Inventory Turnover | 2.45 | 2.28 | 2.35 | 2.65 | 3.26 | 4.48 | Upgrade
|
| Quick Ratio | 3.77 | 4.17 | 3.91 | 3.92 | 3.64 | 2.98 | Upgrade
|
| Current Ratio | 4.67 | 4.86 | 4.74 | 4.53 | 4.32 | 3.48 | Upgrade
|
| Return on Equity (ROE) | 4.16% | 4.68% | 2.03% | 6.84% | 7.50% | 10.58% | Upgrade
|
| Return on Assets (ROA) | 1.29% | 2.07% | 0.99% | 3.35% | 3.40% | 4.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 2.66% | 4.69% | 2.01% | 8.39% | 8.85% | 11.11% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.30% | 3.70% | 1.80% | 5.90% | 6.10% | 7.40% | Upgrade
|
| Earnings Yield | 1.25% | 1.41% | 0.51% | 1.16% | 1.27% | 2.21% | Upgrade
|
| FCF Yield | 1.13% | 2.68% | 1.96% | -0.56% | 0.36% | 1.24% | Upgrade
|
| Dividend Yield | 0.71% | 0.66% | 0.33% | 0.35% | 0.28% | 0.21% | Upgrade
|
| Payout Ratio | 47.58% | 46.26% | 92.25% | 23.42% | 14.60% | 16.26% | Upgrade
|
| Buyback Yield / Dilution | -0.05% | -0.02% | -3.60% | -0.49% | -0.06% | -0.21% | Upgrade
|
| Total Shareholder Return | 0.66% | 0.64% | -3.27% | -0.14% | 0.22% | 0.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.